Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia

PURPOSE: To evaluate the efficacy and safety of 500 mg of nemonoxacin administered orally once daily to outpatients with community-acquired pneumonia (CAP). PATIENTS AND METHODS: Patients with CAP who received nemonoxacin monotherapy were selected from outpatients who visited the Department of Pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bo, Yu, Xiaoxu, Chen, Rui, Zheng, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337426/
https://www.ncbi.nlm.nih.gov/pubmed/32669862
http://dx.doi.org/10.2147/IDR.S248092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337426/
https://www.ncbi.nlm.nih.gov/pubmed/32669862
http://dx.doi.org/10.2147/IDR.S248092

Ejemplares similares